Characterization of the 9L gliosarcoma implanted in the Fischer rat: An orthotopic model for a grade IV brain tumor

Tumor Biology

Volumn 35, Issue 7, 2014, Pages 6221-6233

  Bouchet, Audrey ^a,b,g   Bidart, Marie ^a,d   Miladi, Imen ^c,f   Le Clec'h, Céline ^b,h   Serduc, Raphaël ^a,b   Coutton, Charles ^d   Regnard, Pierrick ^b,i   Khalil, Enam ^b,j   Dufort, Sandrine ^e,f   Lemasson, Benjamin ^a   Laissue, Jean ^g   Pelletier, Laurent ^a,d   Le Duc, Géraldine ^b  

^a GRENOBLE INSTITUT DES NEUROSCIENCES   (France)

^b EUROPEAN SYNCHROTRON RADIATION FACILITY   (France)

^c UNIVERSITÉ DE LYON   (France)

^d GRENOBLE UNIVERSITY HOSPITAL   (France)

^e Nano H SAS   (France)

^f INSERM   (France)

^g UNIVERSITY OF BERN   (Switzerland)

^h CEA GRENOBLE   (France)

ⁱ Fort Foch   (France)

^j UNIVERSITY OF JORDAN   (Jordan)

more..

Author keywords

9L; Cytogenetic; Glioma; Hypervascularization; Infiltration; Radiotherapy; Rat

Indexed keywords

CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; PROTEIN MDM2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BRAIN TUMOR; CANCER MODEL; CANCER RADIOTHERAPY; CAUDATE NUCLEUS; CELL INFILTRATION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CYTOGENETICS; FISCHER 344 RAT; GLIOSARCOMA; HISTOLOGY; IMMUNOHISTOCHEMISTRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; REVIEW; TUMOR CELL; TUMOR GROWTH; VASCULARIZATION;

ANIMALS; BRAIN NEOPLASMS; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; GLIOSARCOMA; HUMANS; NEOPLASM GRADING; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; RATS; RATS, INBRED F344;

EID: 84905036853     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-1783-6     Document Type: Review

References (38)

1. Aronen HJ, Gazit IE, Louis DN, Buchbinder BR, Pardo FS, Weisskoff RM, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology. 1994;191:41-51.
2. Asai A, Miyagi Y, Sugiyama A, Gamanuma M, Hong SH, Takamoto S, et al. Negative effects of wild-type p53 and s-Myc on cellular growth and tumorigenicity of glioma cells. Implication of the tumor suppressor genes for gene therapy. J Neurooncol. 1994;19:259-68. (Pubitemid 24296634)
3. Barth RF. Rat brain tumor models in experimental neuro-oncology: the 9 L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas. J Neurooncol. 1998;36:91-102. (Pubitemid 28230658)
4. Barth RF, Kaur B. Rat brain tumor models in experimental neurooncology: the C6, 9 L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas. J Neurooncol. 2009;94:299-312.
5. Bencokova Z, Pauron L, Devic C, Joubert A, Gastaldo J, Massart C, et al. Molecular and cellular response of the most extensively used rodent glioma models to radiation and/or cisplatin. J Neurooncol. 2008;86:13-21. (Pubitemid 350263428)
6. Benda P, Someda K, Messer J, Sweet WH. Morphological and immunochemical studies of rat glial tumors and clonal strains propagated in culture. J Neurosurg. 1971;34:310-23.
7. Bouchet A, Boumendjel A, Khalil E, Serduc R, Brauer E, Siegbahn EA, et al. Chalcone JAI-51 improves efficacy of synchrotron microbeam radiation therapy of brain tumors. J Synchrotron Radiat. 2012;19:478-82.
8. Bouchet A, Lemasson B, Leduc G, Maisin C, Bräuer-Krisch E, Siegbahn AE, et al. Preferential effect of synchrotron microbeam radiation therapy on intracerebral 9L gliosarcoma vascular networks. Int J Radiat Oncol Biol Phys. 2010;78:1503-12.
9. Bouchet A, Lemasson B, Christen T, Potez M, Rome C, Coquery N, et al.: Synchrotron microbeam radiation therapy induces hypoxia in intracerebral gliosarcoma but not in the normal brain. Radiother Oncol. 2013
10. Coniglio SJ, Segall JE: Review: molecular mechanism of microglia stimulated glioblastoma invasion. Matrix Biol. 2013.
11. Darpolor MM, Molthen RC, Schmainda KM. Multimodality imaging of abnormal vascular perfusion and morphology in preclinical 9L gliosarcoma model. PLoS One. 2011;6:e16621.
12. Denlinger RH, Axler DA, Koestner A, Liss L. Tumor-specific transplantation immunity to intracerebral challenge with cells from a methylnitrosourea- induced brain tumor. J Med. 1975;6:249-59.
13. Goldbrunner RH, Wagner S, Roosen K, Tonn JC. Models for assessment of angiogenesis in gliomas. J Neuro Oncol. 2000;50:53-62. (Pubitemid 32166290)
14. Huse JT, Holland EC. Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma. Nat Rev Cancer. 2010;10:319-31.
15. Jacobs VL, Valdes PA, Hickey WF, De Leo JA. Current review of in vivo GBM rodent models: emphasis on the CNS-1 tumour model. ASN Neurol. 2011;3:e00063.
16. Karsy M, Gelbman M, Shah P, Balumbu O, Moy F, Arslan E. Established and emerging variants of glioblastoma multiforme: review of morphological and molecular features. Folia Neuropathol. 2012;50:301-21.
17. Kruse CA, Molleston MC, Parks EP, Schiltz PM, Kleinschmidt-DeMasters BK, Hickey WF. A rat glioma model, CNS-1, with invasive characteristics similar to those of human gliomas: a comparison to 9L gliosarcoma. J Neuro Oncol. 1994;22:191-200.
18. Le Duc G, Miladi I, Alric C, Mowat P, Bräuer-Krisch E, Bouchet A, et al. Toward an image-guided microbeam radiation therapy using gadolinium-based nanoparticles. ACS Nano. 2011;5:9566-74.
19. Lemasson B, Christen T, Tizon X, Farion R, Fondraz N, Provent P, et al. Assessment of multiparametric MRI in a human glioma model tomonitor cytotoxic and anti-angiogenic drug effects. NMR Biomed. 2011;24:473-82.
20. Lemasson B, Serduc R, Maisin C, Bouchet A, Coquery N, Robert P, et al. Monitoring blood-brain barrier status in a rat model of glioma receiving therapy: dual injection of low-molecular-weight and macromolecular MR contrast media. Radiology. 2010;257:342-52.
21. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114:97-109. (Pubitemid 47103521)
22. Maeda M, Itoh S, Kimura H, Iwasaki T, Hayashi N, Yamamoto K, et al. Tumor vascularity in the brain: evaluation with dynamic susceptibility-contrast MR imaging. Radiology. 1993;189:233-8. (Pubitemid 23292954)
23. Malkin D, Li FP, Strong LC, Fraumeni JF, Nelson CE, Kim DH, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science. 1990;250:1233-8. (Pubitemid 120031831)
24. Pathak AP, Schmainda KM, Ward BD, Linderman JR, Rebro KJ, Greene AS. MR-derived cerebral blood volume maps: issues regarding histological validation and assessment of tumor angiogenesis. Magn Reson Med. 2001;46:735-47. (Pubitemid 32906143)
25. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell. 2006;9:157-73. (Pubitemid 43357943)
26. Regnard P, DucGL, Bräuer-Krisch E, Tropres I, Siegbahn EA, Kusak A, et al. Irradiation of intracerebral 9L gliosarcoma by a single array of microplanar x-ray beams from a synchrotron: balance between curing and sparing. Phys Med Biol. 2008;53:861-8.
27. Régnard P, Bräuer-Krisch E, Troprès I, Keyriläinen J, Bravin A, Le Duc G. Enhancement of survival of 9L gliosarcoma bearing rats following intracerebral delivery of drugs in combination with microbeam radiation therapy. Eur J Radiol. 2008;68:S151-5.
28. Serduc R, Bouchet A, Brauer-Krisch E, Laissue JA, Spiga J, Sarun S, et al. Synchrotron microbeam radiation therapy for rat brain tumor palliation-influence of the microbeam width at constant valley dose. Phys Med Biol. 2009;54:6711-24.
29. Serduc R, Brauer-Krisch E, Bouchet A, Renaud L, Brochard T, Bravin A, et al. First trial of spatial and temporal fractionations of the delivered dose using synchrotron microbeam radiation therapy. J Synchrotron Radiat. 2009;16:587-90.
30. Serduc R, Christen T, Laissue J, Farion R, Bouchet A, van der Sanden B, et al. Brain tumor vessel response to synchrotron microbeam radiation therapy: a short-term in vivo study. Phys Med Biol. 2008;53:3609-22. (Pubitemid 352020044)
31. Serduc R, Verant P, Vial JC, Farion R, Rocas L, Remy C, et al. In vivo two-photon microscopy study of short-term effects of microbeam irradiation on normal mouse brain microvasculature. Int J Radiat Oncol Biol Phys. 2006;64:1519-27.
32. Sibenaller ZA, Etame AB, Ali MM, Barua M, Braun TA, Casavant TL, et al. Genetic characterization of commonly used glioma cell lines in the rat animal model system. Neurosurg Focus. 2005;19:E1.
33. Stojiljkovic M, Piperski V, Dacevic M, Rakic L, Ruzdijic S, Kanazir S: Characterization of 9L glioma model of the Wistar rat. J Neurooncol. 2003;63:1-7, Available: http://www.ncbi.nlm.nih.gov/pubmed/12814248. Accessed 23 January 2013.
34. Strakova N, Ehrmann J, Dzubak P, Bouchal J, Kolar Z. The synthetic ligand of peroxisome proliferator-activated receptor-gamma ciglitazone affects human glioblastoma cell lines. J Pharmacol Exp Ther. 2004;309:1239-47. (Pubitemid 38669715)
35. Tropres I, Grimault S, Vaeth A, Grillon E, Julien C, Payen JF, et al. Vessel size imaging. Magn Reson Med. 2001;45:397-408. (Pubitemid 32173265)
36. Tropres I, Lamalle L, Peoc'h M, Farion R, Usson Y, Decorps M, et al. In vivo assessment of tumoral angiogenesis. Magn Reson Med. 2004;51:533-41. (Pubitemid 38298667)
37. Valable S, Lemasson B, Farion R, Beaumont M, Segebarth C, Remy C, et al. Assessment of blood volume, vessel size, and the expression of angiogenic factors in two rat glioma models: a longitudinal in vivo and ex vivo study. NMR Biomed. 2008;21:1043-56.
38. Zhou Y, Su Z, Huang Y, Sun T, Chen S, Wu T, et al. The Zfx gene is expressed in human gliomas and is important in the proliferation and apoptosis of the human malignant glioma cell line U251. J Exp Clin Cancer Res. 2011;30:114.